| Unraveling the mechanism of protein disaggregation through a ClpB-DnaK interaction R Rosenzweig, S Moradi, A Zarrine-Afsar, JR Glover, LE Kay Science 339 (6123), 1080-1083, 2013 | 283 | 2013 |
| The structure of the atypical killer cell immunoglobulin-like receptor, KIR2DL4 S Moradi, R Berry, P Pymm, C Hitchen, SA Beckham, MCJ Wilce, ... Journal of Biological Chemistry 290 (16), 10460-10471, 2015 | 56 | 2015 |
| Antibacterial, antifungal and toxicity of rare Iranian plants. K Keymanesh, J Hamedi, S Moradi, F Mohammadipanah, S Sardari IJP-International Journal of Pharmacology 5 (1), 81-85, 2009 | 43 | 2009 |
| Structural plasticity of KIR2DL2 and KIR2DL3 enables altered docking geometries atop HLA-C S Moradi, S Stankovic, GM O’connor, P Pymm, BJ MacLachlan, C Faoro, ... Nature Communications 12 (1), 2173, 2021 | 27 | 2021 |
| Peptidomimetics and their applications in antifungal drug design S Moradi, S Soltani, AM Ansari, S Sardari Anti-Infective Agents in Medicinal Chemistry (Formerly Current Medicinal …, 2009 | 26 | 2009 |
| Antifungal indole and pyrrolidine-2, 4-dione derivative peptidomimetic lead design based on in silico study of bioactive peptide families S Moradi, P Azerang, V Khalaj, S Sardari Avicenna Journal of Medical Biotechnology 5 (1), 42, 2013 | 7 | 2013 |
| Molecular basis of the human leukocyte antigen (HLA) recognition by inhibitory killer cell immunoglobulin-like receptors (KIRs) S Moradi Monash University, 2017 | | 2017 |
| Interaction of Hsp104 with Hsp70: insight into the mechanism of protein disaggregation S Moradi | | 2013 |
| Antifungal Peptide Modeling, Folding and Mimetic Design S Moradi Universiti Putra Malaysia, 2009 | | 2009 |
| Structural insights into the killer-cell immunoglobulin-like receptor family JP Vivian, S Moradi, PM Saunders, P Pymm, AG Brooks, J Rossjohn SCANZ—CRYSTAL 31 Abstracts—2017, 61, 0 | | |
